FDA Inspection 1222178 — Viorel Jinga, M.D., Ph.D.
The FDA completed an inspection of Viorel Jinga, M.D., Ph.D. on October 13, 2023 in Bucharest. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bucharest (Romania)
Additional Details
Clinical Investigator (CI)